可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Falk E, Shah PK,Fuster V. Coronary plaque disruption[J]. Circulation,1995,92 (3):657-671.
[2] Dollery CM, McEwan JR,Henney AM. Matrix metalloproteases and cardiovascular disease[J]. Circ Res, 1995,77(5):863–868.
[3] Ross R. Atherosclerosis——an inflammatory disease[J]. N Engl J Med,1999,340(2):115-126.
[4] 许俊堂,胡大一. 对急性冠脉综合征分型的看法[J]. 中华心血管杂志,2001,29(9):566-568.
[5] Sukhova GK,Schonbeck U,Rabkin E. Evidence for increased collagenolysis by interstitial collagenases1 and 3 in vulnerable human atheromatous laques[J]. Circulation,1999,99(19):2503-2509.
[6] Herman MP,Sukhova GK,Libby P. Expression of neutrophil collagenase(matrix metalloprotease8) in human atheroma :a novel collagenic pathway suggested by transcriptional profiling[J]. Circulation,2001,104(16):1899-1904.
[7] Kai H,Ikeda H,Yasukawa H,et al. Peripheral blood levels of matrix metalloproteinases2 and 9 are elevated in pations with acute coronary syndrome[J]. J Am Coll Cardiol,1998,32(2):368-372.
[8] 罗明,俞文萍,王宏保. 辛伐他汀联合依那普利干预对急性冠脉综合征患者血清C反应蛋白和白介素6的影响[J]. 心脏杂志,2005,17(2):137-139.
[9] Saren P.Welgus HG,Kovanen PT. TNFα and IL1β selectively induce expression of 92kDa gelatinase by human macrophages[J]. J Immunol,1996,157(9):4159-4165.
[10]Cahill MR,Perry IJ. Inflammation,aspirin,and the risk of cardiovascular disease[J]. N Engl J Med,1997,337(6):422-423.